IRAK-M is involved in the pathogenesis of early-onset persistent asthma.

TLDR: The data suggest a mechanistic link between hyperactivation of the innate immune system and chronic airway inflammation and indicate IRAK-M as a potential target for therapeutic intervention against asthma.

Abstract: Asthma is a multifactorial disease influenced by genetic and environmental factors In the past decade, several loci and >100 genes have been found to be associated with the disease in at least one population Among these loci, region 12q13-24 has been implicated in asthma etiology in multiple populations, suggesting that it harbors one or more asthma susceptibility genes We performed linkage and association analyses by transmission/disequilibrium test and case-control analysis in the candidate region 12q13-24, using the Sardinian founder population, in which limited heterogeneity of pathogenetic alleles for monogenic and complex disorders as well as of environmental conditions should facilitate the study of multifactorial traits We analyzed our cohort, using a cutoff age of 13 years at asthma onset, and detected significant linkage to a portion of 12q13-24 We identified IRAK-M as the gene contributing to the linkage and showed that it is associated with early-onset persistent asthma We defined protective and predisposing SNP haplotypes and replicated associations in an outbred Italian population Sequence analysis in patients found mutations, including inactivating lesions, in the IRAK-M coding region Immunohistochemistry of lung biopsies showed that IRAK-M is highly expressed in epithelial cells We report that IRAK-M is involved in the pathogenesis of early-onset persistent asthma IRAK-M, a negative regulator of the Toll-like receptor/IL-1R pathways, is a master regulator of NF-κB and inflammation Our data suggest a mechanistic link between hyperactivation of the innate immune system and chronic airway inflammation and indicate IRAK-M as a potential target for therapeutic intervention against asthma